Lab at the Kennedy Institute of Rheumatology, University of Oxford.
@natcomms.bsky.social, we described that immune cells can adapt to IFNg-driven escape, enhancing their fitness and thereby counteracting tumour escape www.nature.com/articles/s41...
You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
www.kennedy.ox.ac.uk/news/dr-fran...
@thelisterinstitute.bsky.social @franzeprogatzky.bsky.social
www.kennedy.ox.ac.uk/news/dr-fran...
@thelisterinstitute.bsky.social @franzeprogatzky.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Platforms for studying cell–cell recognition by immune cells
onlinelibrary.wiley.com/doi/10.1111/...
Platforms for studying cell–cell recognition by immune cells
onlinelibrary.wiley.com/doi/10.1111/...
We have been getting reports that, under some more inflammatory settings like TB or chronic LCMV infection, uLIPSTIC-expressing lymphocytes adoptively transferred into cre-negative uLIPSTIC hosts may be rejected at later timepoints (>1 wk).
We have been getting reports that, under some more inflammatory settings like TB or chronic LCMV infection, uLIPSTIC-expressing lymphocytes adoptively transferred into cre-negative uLIPSTIC hosts may be rejected at later timepoints (>1 wk).
Big thanks to this year's sponsors:
@10xgenomics.bsky.social
@Immunocore
@nanoporetech.com
@imtadvances.bsky.social
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
Proud of my group and collaborators for this work published today in Nature Medicine. We find Cytomegalovirus, which has a profound impact on T cell immunity, is associated with distinct clinical outcomes in patients receiving checkpoint immunotherapy for melanoma.
🥼 We are open to applications from Medical Undergraduates
📚 We also have 3 GSK-Oxford DPhil studentships available.
📢 Deadline: Noon 25th April.
Apply below ⬇️ @medsci.ox.ac.uk
www.cancer.ox.ac.uk/study#how-to...
🥼 We are open to applications from Medical Undergraduates
📚 We also have 3 GSK-Oxford DPhil studentships available.
📢 Deadline: Noon 25th April.
Apply below ⬇️ @medsci.ox.ac.uk
www.cancer.ox.ac.uk/study#how-to...
Work lead by David Lecky & Lozan Sheriff in collaboration with @therad-lab.bsky.social and @cameron-wraith.bsky.social showing how IFNg augments T Cell receptor signal strength to enhance type 1 Regulatory T (Tr1) cell development
www.cell.com/iscience/ful...
Work lead by David Lecky & Lozan Sheriff in collaboration with @therad-lab.bsky.social and @cameron-wraith.bsky.social showing how IFNg augments T Cell receptor signal strength to enhance type 1 Regulatory T (Tr1) cell development
www.cell.com/iscience/ful...
Absolutely delighted to share our last paper on "spatial mechano-transcriptomics" @naturemethods👇!!
www.nature.com/articles/s41...
Absolutely delighted to share our last paper on "spatial mechano-transcriptomics" @naturemethods👇!!
www.nature.com/articles/s41...
rdcu.be/ebfVl
rdcu.be/ebfVl
📍 Where: Basel, Switzerland
📅 When: 26th–29th August 2025
📝 Registration deadline: 30th May 2025
Check out the program and details 🔗
#EMBOBarrierTissues @embo.org
📍 Where: Basel, Switzerland
📅 When: 26th–29th August 2025
📝 Registration deadline: 30th May 2025
Check out the program and details 🔗
#EMBOBarrierTissues @embo.org
We are looking for talented, highly motivated, and collaborative individuals to join our dynamic team as:
🔬 Research Assistant
www.kennedy.ox.ac.uk/jobs/researc...
💻 Bioinformatics Postdoc
www.kennedy.ox.ac.uk/jobs/bioinfo...
📢 Please share!
We are looking for talented, highly motivated, and collaborative individuals to join our dynamic team as:
🔬 Research Assistant
www.kennedy.ox.ac.uk/jobs/researc...
💻 Bioinformatics Postdoc
www.kennedy.ox.ac.uk/jobs/bioinfo...
📢 Please share!
doi.org/10.1084/jem....
doi.org/10.1084/jem....
@sciimmunology.bsky.social @mmr2.bsky.social
www.science.org/doi/10.1126/...
@sciimmunology.bsky.social @mmr2.bsky.social
www.science.org/doi/10.1126/...
The 3D affinities of the OT-I TCR to foreign and self-antigens predict their 2D affinities and reveal imperfect antigen discrimination
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...